Lv1
54 积分 2023-12-12 加入
The use of cell-free DNA (cfDNA)/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer
1个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
2个月前
已完结
Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives
2个月前
已关闭
Antibody-Drug Conjugates in the Management of Breast Cancer
2个月前
已关闭
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment
5个月前
已完结
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence
9个月前
已关闭
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence
9个月前
已关闭
Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention
9个月前
已完结
HER2-Positive Breast Cancer Treatment and Resistance
9个月前
已完结
Molecular Classification of Breast Cancer
9个月前
已完结
皖公网安备34019202002308
